Professional Documents
Culture Documents
Q3 Enlists six paths of transforming a business. Explain any one with example. 5 marks CO1
Q4 How organizations can break the value – cost tradeoff? 5 marks CO1
Q5 Enlist various tools to predict failure. Discuss any one in detail. 5 marks CO2
Q6 In March 2015, CSB Bank (formerly Catholic Syrian Bank), had filed for an IPO CO3 &
to raise Rs 400 crore, but the plan was shelved for lack of interest. CSB was set CO4
up in 1920 to serve the Syrian Christian community in Kerala.
In 2017, CSB again tried — and failed — to raise money from various investors,
including private equity.
Today, after a year since it listed on December 4, 2019, its market cap is more
than the combined valuation of its southern private banking peers.
Let us go back to history
To start with, CSB did not conform to the Reserve Bank of India (RBI) guidelines
on foreign shareholding.
It was only in 2010 that the bank started reducing the stake of its largest
shareholder, Bangkok-based entrepreneur Sura Chansrichawla, from 34 per cent
to less than 10 per cent (as of 2016-17).
Though the RBI mandated one year, it took Chansrichawla three or four years to
Page 1 of 2
comply.
The years 2010 to 2017 saw internal board struggles that caused the management
to take its eye off the ball.
During those days, CSB set itself the target of doubling its balance sheet by
expanding its corporate lending business.
Lacking experience, it joined bank lending consortia.
But once the economic slowdown began, CSB started feeling the heat with many
corporate accounts turning into non-performing assets (NPA). This was true for
the banking sector as a whole but CSB’s case was extreme since corporate lending
accounted for a quarter of its loans.
In 2015-16, the bank recorded the losses of Rs 149 crore.
“It was a small, extreme adventure. We accepted the failure and we were open
about it to all the stakeholders, including new investors,” said T S Anantharaman,
who was chairman of CSB between 2017 and 2018.
The losses were mounting. A capital infusion was the immediate need but three
rights issues is the past ruled out accessing existing shareholders.
Page 3 of 2